Compulsory licensing for expensive medicines

Publikation: Bog/antologi/afhandling/rapportRapportfagfællebedømt

  • Esther Van Zimmeren
  • Minssen, Timo
  • Liesbet Paemen
  • Walter Van Dyck
  • Jeroen Luyten
  • Rosanne Janssens
  • Liese Barbier
  • Steven Simoens
  • Celine Pouppez (Redaktør)
  • Irina Cleemput (Redaktør)
  • Imgard Vinck (Redaktør)
Van Zimmeren E, Minssen T, Paemen L, Van Dyck W, Luyten J, Janssens R, Barbier L, Simoens S, Pouppez C, Cleemput I, Vinck I. Compulsory licensing for expensive medicines. Health Services Research (HSR) Brussels: Belgian Health Care Knowledge Centre (KCE). 2022. KCE Reports 356. D/2022/10.273/35. This document is available on the website of the Belgian Health Care Knowledge Centre.
OriginalsprogEngelsk
UdgivelsesstedBrussels
ForlagBelgian Health Care Knowledge Centre (KCE).
Antal sider200
StatusUdgivet - 14 jun. 2022

ID: 310249981